Elabscience

NOG Polyclonal Antibody

Product Code:
 
E-AB-19756
Product Group:
 
Primary Antibodies
Supplier:
 
Elabscience
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
  • Human
  • Mouse
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
Shipping:
 
Ice packs
Storage:
 
Store at -20°C. Avoid freeze / thaw cycles.
1 / 2
Immunohistochemistry of paraffin-embedded Human liver cancer tissue  using NOG Polyclonal Antibody at dilution of 1:40(?200)
2 / 2
Immunohistochemistry of paraffin-embedded Human esophagus cancer tissue  using NOG Polyclonal Antibody at dilution of 1:40(?200)

Immunohistochemistry of paraffin-embedded Human liver cancer tissue  using NOG Polyclonal Antibody at dilution of 1:40(?200)
Immunohistochemistry of paraffin-embedded Human esophagus cancer tissue  using NOG Polyclonal Antibody at dilution of 1:40(?200)

No additional charges, what you see is what you pay! *

CodeSizePrice
E-AB-19756-20uL20uL£125.00
Quantity:
E-AB-19756-60uL60uL£172.00
Quantity:
E-AB-19756-120uL120uL£237.00
Quantity:
E-AB-19756-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: China.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Abbreviation:
NOG
Background:
NOG (Noggin) is a Protein Coding gene. Diseases associated with NOG include Tarsal-Carpal Coalition Syndrome and Brachydactyly, Type B2. Among its related pathways are Mesodermal Commitment Pathway and Differentiation Pathway. GO annotations related to this gene include protein homodimerization activity and cytokine binding.The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene.
Buffer:
PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Concentration:
1.4 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:30-1:150, ELISA 1:5000-1:10000
Immunogen:
Synthetic peptide of human NOG
Purification method:
Antigen affinity purification
Target Synonym:
Nog;NOGG;Noggin;SYM 1;SYM1;Symphalangism 1 (proximal);Synostoses (multiple) syndrome 1;SYNS 1;SYNS1
UNIProt ID:
Q13253

Documents